611 results on '"Mansukhani, Mahesh"'
Search Results
52. Evaluation of Surgical Energy Devices for Vessel Sealing and Peripheral Energy Spread in a Porcine Model
53. Incidence and Clinical Significance of Lymph Node Metastasis Detected by Cytokeratin Immunohistochemical Staining in Ductal Carcinoma In Situ
54. Survival and Recurrence After Breast Cancer in BRCA1/2 Mutation Carriers
55. Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells
56. Genetic analysis identifies putative tumor suppressor sites at 2q35–q36.1 and 2q36.3–q37.1 involved in cervical cancer progression
57. PAX2: a reliable marker for nephrogenic adenoma
58. Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors
59. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy
60. A Comparison of the Outcomes of Neoadjuvant and Adjuvant Chemotherapy for Clinical T2–T4aN0–N2M0 Bladder Cancer
61. Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas
62. LGG-22. EVALUATION OF IMMUNE AND GENOMIC CHARACTERISTICS IN PEDIATRIC OPTIC NERVE GLIOMA (ONG)
63. Clinical Utilization, Utility, and Reimbursement for Expanded Genomic Panel Testing in Adult Oncology
64. Spontaneous Regression and Complete Response to Immune Checkpoint Blockade in a Case of High-Grade Neuroendocrine Carcinoma
65. Assay Complementarity to Overcome False-Negative Testing for Microsatellite Instability/Mismatch Repair Deficiency: A Pembrolizumab-Sensitive Intimal Sarcoma
66. Predictive testing for neurodegenerative diseases in the age of next‐generation sequencing
67. Diffuse midline glioma with novel, potentially targetable, FGFR2–VPS35 fusion
68. Abstract 171: Genomic and phenotypic analysis of post-transplant plasmablastic lymphomas
69. Field-deployable, rapid diagnostic testing of saliva samples for SARS-CoV-2
70. Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction
71. 6. Multiplexed-PCR based next generation sequencing assay for diagnosis of bladder carcinoma in urine specimens
72. 62. Ph+ ALL: Clonal evolution with ABL1 KD and SETD2 variants
73. Efficacy of DNA versus RNA NGS-based Methods in MET Exon 14 skipping mutation detection.
74. Refractory celiac disease type II: An atypical case highlighting limitations of the current classification system
75. SETD2 Mutation in an Aggressive Optic Nerve Glioma
76. Atypical glandular cells (AGC): ThinPrep Imaging System (TIS), manual screening (MS), and correlation with Hybrid Capture 2 (HC2) HPV DNA testing
77. Results of the Southwest Oncology Group phase II evaluation (study S0031) of ZD1839 for advanced transitional cell carcinoma of the urothelium
78. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors
79. Lack of PTEN sequesters CHK1 and initiates genetic instability
80. Prenatal diagnosis of congenital lipoid adrenal hyperplasia (CLAH) by estriol amniotic fluid analysis and molecular genetic testing
81. Targeting SLMAP-ALK—a novel gene fusion in lung adenocarcinoma
82. High-Risk Human Papillomavirus DNA Testing: A Marker for Atypical Glandular Cells
83. Mature B-cell acute lymphoblastic leukemia with t(9;11) translocation: a distinct subset of B-cell acute lymphoblastic leukemia
84. A contemporary evaluation of cytoreductive nephrectomy with tumor thrombus: Morbidity and long-term survival
85. EBV-associated, extranodal NK-cell lymphoma, nasal type of the breast, after heart transplantation
86. Progenitor cell expansion: an important source of hepatocyte regeneration in chronic hepatitis
87. Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1
88. ZTTK syndrome: Clinical and molecular findings of 15 cases and a review of the literature.
89. Rheumatoid nodules of the antihelix: a case report
90. Is Hispanic Race an Independent Risk Factor for Pathological Stage in Patients Undergoing Radical Prostatectomy?
91. Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/ neu-expressing experimental Wilms’ tumor
92. Malignant Rhabdoid Tumor, an Aggressive Tumor Often Misclassified as Small Cell Variant of Hepatoblastoma
93. Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract
94. Microsatellite instability detection using a large next-generation sequencing cancer panel across diverse tumour types
95. Utility of en-face imaging in diagnosis of occult macular dystrophy with RP1L1 mutation: A case series
96. Cytogenetic analysis of 130 renal oncocytomas identify three distinct and mutually exclusive diagnostic classes of chromosome aberrations
97. Targeting SLMAP-ALK—a novel gene fusion in lung adenocarcinoma
98. Clinical utility and reimbursement for expanded genomic panel testing in adult oncology.
99. A phase II study for prostate cancer monitoring using 18F-DCFPyL and blood-based biomarkers.
100. Identification of a secondary RET mutation in a pediatric patient with relapsed acute myeloid leukemia leads to the diagnosis and treatment of asymptomatic metastatic medullary thyroid cancer in a parent: a case for sequencing the germline
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.